- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Italy's Money-Back Guarantee for Cancer Treatments
January 19, 2016.
Italy’s state-run health service is demanding a money-back guarantee when trying new cancer treatments, Bloomsberg Business reports. The Italian Medicines Agency will pay pharma companies according to how well a patient responds to treatment. In some cases, where the medication fails to help, the drugmaker must provide a full refund. Through this method, approximately 200 million euros ($220 million) was refunded to the Italian government for ineffective treatments last year, amounting to about 1 percent of total pharmaceutical spending. With global oncology expected to reach $100 billion in 2018, Bloomsberg adds that Italy's money-back experiment is being monitored in the U.S. and across Europe. http://www.bloomberg.com/news/articles/2016-01-15/when-new-cancer-treatments-fail-italy-wants-its-money-back
